INTRAFRACTION PROSTATE MOTION MANAGEMENT

The raypilot system

Enabling accuracy in prostate cancer care

The Raypilot System is an electromagnetic positioning system that continuously localizes the prostate during radiation therapy. The system includes a transmitter which tracks the prostate tumour movements and outlines the urethra in real-time 3D, thus enhancing treatment precision and enabling a significant reduction of the risk of damaging surrounding healthy tissue. The precision makes it possible to use higher radiation dose and treatment may be given in a week or less, compared to conventional therapy over an 8-week period.

Healthcare professionals about Raypilot

“The reported significantly increased toxicity for SBRT vs standard IMRT was mostly urethra related. Having the possibility to identify the urethra using the Raypilot Hypocath gives us the opportunity to reduce the urethral dose without underdosing the tumour, thus delivering a safer treatment.”

Medical Physicist Denis Panizza, San Gerardo Hospital, Monza, Italy

“Raypilot Hypocath enables us to keep track of prostate motion during SBRT treatments where the precise dose to the target and strict tolerance to the surrounding organs is paramount.”

Professor Stefano Arcangeli, Head of Radiation Oncology, San Gerardo Hospital, Monza, Italy

”Raypilot is a game changer for our clinic. Being able to track tumour movements in real time reduces the margins and removes the uncertainty we previously felt about hypofractionation. It helps us treat more patients through hypofractionation. The results so far have been very promising.”

Professor Duncan McLaren, Consultant Clinical Oncologist, Edinburgh Cancer Centre, Western General Hospital, Scotland

”Very user-friendly system. Very easy to understand and supports us a lot in the standard workflow. This system has the potential to become a valuable asset when using SBRT protocols for treating prostate cancer.”

Professor Felix Sedlmayer, Department of Radiotherapy and Radio-Oncology, LKH Salzburg, Austria and Paracelsus Medical University, Salzburg, Austria

BENEFITS

OUTLINING OF URETHRA

REPRODUCIBILITY OF BLADDER FILLING

RIGHT DOSE DELIVERED TO RIGHT TARGET

Treatment process

Patient workflow – from start to finish

The Raypilot System keeps track of the prostate during patient set up and treatment. Motion monitoring in real-time enables you to safely minimize the margins. Predefined margins are chosen for the tolerance margins by the physician. When margins are exceeded during the treatment sessions the Raypilot System alerts the user and the treatment is stopped. Data from the treatment is stored and saved for the user to access and analyze.

DIAGNOS

The patient is assigned radiotheraphy treatment by his pyshican. The treatment monitoring of prostate motion is enabled by the Raypilot System.

DIAGNOS

PLANNING

During the planning session the Raypilot Viewcath is inserted to simulate the same situation as in the coming treatment with the Raypilot Hypocath.

CT is performed and bladder filling is done according to clinical routine. After the CT is done the Raypilot Viewcath is removed.

Outlining of the urethra is performed by the physician.

PLANNING

SHORT WAITING TIME

Patient is scheduled for treatment (generally 1-7 days wait).

SHORT WAITING TIME

FIRST TREATMENT

Now the physician can perform a safe real-time control urethra-sparing treatment.

Patient arrives and the Raypilot Hyopcath is inserted.
The bladder is filled with same volume as planned – reproducibility of the bladder filling.
Patient treatment starts (15 min average treatment time*).

Raypilot keeps track of the prostate motion during patient set up and throughout the treatment.

FIRST TREATMENT

SINGLE SHOT

Single shot treatment:
After finished treatment the Raypilot Hypocath is removed, and patient goes home.

SINGLE SHOT

2 OR MORE SESSIONS

Between the treatment sessions the patient goes home with the Raypilot Hypocath catheter and comes back for the next scheduled session.

2 OR MORE SESSIONS

LAST TREATMENT

After the last treatment session, The Raypilot Hypocath is removed. Individual follow-up depending on clinical routine.

LAST TREATMENT

AFTER TREATMENT

Routine scheduled visits and follow up at the clinic according to local routine.

AFTER TREATMENT

*Average treatment time 10.2 minutes, Monza Protocol, S.Gerardo Hospital, Monza, Italy. Read study


PATIENT STORIES

– I have not had any side effects. My way of life hasn´t changed at all.

Mr Cattaneo Giorgio, treated at San Gerardo Hospital in Monza, Italy.

Meet 79-year-old Mr Cattaneo Giorgio. He was treated for prostate cancer in four sessions performed in four consecutive days. The use of Raypilot allows faster as well as more effective and safe treatments.


  • Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion

    Read article

latest publications


  • State of the art and future challenges of urethra‑sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature

    State of the art and future challenges of urethra‑sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature

    ·

    ,
    Read article

  • Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?

    Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?

    ·

    , ,
    Read article

+
Patients helped
+
Clinics served
+
Studies published

Events


ESTRO2024

We are pleased to once again visit ESTRO 2024, from May 3 to May 7 in Glasgow, United Kingdom. ESTRO 2024 will host Europe’s largest industry exhibition in radiation oncology, […]

Find out more »
Scottish Event Campus, Exhibition Way
Glasgow G3 8YW, United Kingdom
+ Google Map

ISRS2024

ISRS 2024 | International Stereotactic Radiosurgery Society A global community of experts who share a passion for Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT) and other focal therapies. Micropos […]

Find out more »
Marriott Marquis Times Square, 1535 Broadway, 10036
New York, NY United States
+ Google Map

DEGRO2024

DEGRO 2024 | The 29th Congress of the German Society for Radiation Oncology. We are happy to be present at this year’s DEGRO in Kassel, Germany 13-1 of June 2023. […]

Find out more »
Congress Palais Kassel, Holger-Börner-Platz 1
kassel,, Germany 34119 Germany
+ Google Map

Follow us on LinkedIn

Let’s keep in touch